Deals Of The Week: Adimab/Mersana, Merck Serono/Prexton, Idenix/Novartis
Enlight’s latest portfolio company, KNODE, soon will launch a search and networking platform to help researchers locate information, identify experts and form communities.
You may also be interested in...
Prexton Therapeutics will be headquartered at the Eclosion incubator facility in Geneva and will advance mGluR compounds for Parkinson’s from the Merck Serono portfolio.
COVID-19 disruptions, less favorable currency and the shadow of drug price reform could mean more headwinds for pharma during this S&E period after a strong Q2.
Congress is considering legislation that would reverse some of the Trump administration's friendly corporate tax policies, presenting another challenge to the biopharmaceutical industry.